Green Pharmaceuticals, Inc.

CourtUnited States Bankruptcy Court, C.D. California
DecidedMay 15, 2020
Docket9:18-bk-12087
StatusUnknown

This text of Green Pharmaceuticals, Inc. (Green Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Green Pharmaceuticals, Inc., (Cal. 2020).

Opinion

1 2 FILED & ENTERED 3 MAY 15 2020 4 5 CLERK U.S. BANKRUPTCY COURT Central District of California BY r u s t DEPUTY CLERK 6 7 8 UNITED STATES BANKRUPTCY COURT 9 CENTRAL DISTRICT OF CALIFORNIA 10 NORTHERN DIVISION 11 12 In re: Case No. 9:18-bk-12087-DS 13 Chapter 11 14 GREEN PHARMACEUTICALS, INC., MEMORANDUM OF DECISION ON 15 CONFIRMATION OF THE DEBTOR’S 16 Debtor. PLAN OF REORGANIZATION

17 18 Green Pharmaceuticals, Inc. (the “Debtor”) seeks confirmation of its chapter 11 plan 19 of reorganization. Having considered the papers, the evidentiary record, and arguments of 20 counsel, the court denies confirmation of the Debtor’s plan based on the following findings 21 of fact and conclusions of law made pursuant to Federal Rule of Civil Procedure 52(a), as 22 incorporated into Federal Rule of Bankruptcy Procedure 7052 and applied to contested 23 matters by Federal Rule of Bankruptcy Procedure 9014(c).1 24 25

26 1 Unless otherwise indicated, all “Code,” “chapter,” and “section” references are to the U.S. Bankruptcy Code, 11 U.S.C. §§ 101-1330 after its amendment by the Bankruptcy Abuse Prevention and Consumer 27 Protection Act of 2005, Pub. L. 109-8, 119 Stat. 23 (2005). “Rule” references are to the Federal Rules of Bankruptcy Procedure (“Fed. R. Bankr. P.”), which make applicable certain Federal Rules of Civil Procedure 1 I. Background 2 The Debtor filed a chapter 11 petition on December 19, 2018. The Debtor 3 manufactures, distributes, and sells sleep and snore products. In 2018, the Debtor had 4 cash flow issues related to attorney fees incurred to defend the Debtor against a false 5 advertising class action lawsuit. The Debtor lost the class action lawsuit on appeal, which 6 resulted in a judgment against the Debtor for over $3 million and led to the filing of this 7 case. 8 On July 1, 2019, the Debtor filed its initial plan of reorganization and disclosure 9 statement. On July 31, 2019, creditors Rachel Rosendez and the certified class (together, 10 the “Certified Class”) filed an objection to the adequacy of initial disclosure statement. On 11 August 14, 2019, the court indicated that the objections were primarily confirmation issues 12 and directed the Debtor to make some minor additions to the disclosure statement to 13 ensure adequate disclosure. The court set deadlines for filing an amended disclosure 14 statement and scheduled an initial confirmation hearing for October 15, 2019. 15 On August 21, 2019, the Debtor filed its First Amended Chapter 11 Plan and its 16 First Amended Disclosure Statement, and on September 11, 2019, the court entered an 17 order approving the Debtor’s First Amended Disclosure Statement (Docket No. 148). The 18 Certified Class and the Law Offices of Joe R. Correa (“Correa”) both filed objections to the 19 confirmation of the Debtor’s First Amended Chapter 11 Plan. The class consisting of 20 holders of general unsecured claims voted to reject the plan. 21 At the initial confirmation hearing on October 15, 2019, the court indicated that it 22 had reviewed and considered the documents that were timely filed and stated that an 23 evidentiary hearing and testimony from the Debtor on confirmation would necessary. The 24 court continued the confirmation hearing to November 14, 2019 to conduct an evidentiary 25 hearing. 26 At the November 14, 2019 evidentiary hearing, the Debtor proffered the testimony 27 of Dominique De Rivel, the Debtor’s principal. After the testimony had concluded on 1 delay a ruling to allow the parties an opportunity to negotiate a potential resolution of the 2 objections to confirmation, and the court adjourned the hearing. 3 On November 26, 2019, the Debtor’s counsel sent a statement to the court that the 4 parties were unable to reach a settlement and requested a decision on plan confirmation. 5 Docket No. 166. The next day, the court set a continued hearing on the confirmation of the 6 Debtor’s First Amended Chapter 11 Plan for December 16, 2019. Docket No. 167. 7 On December 13, 2019, the court entered an order continuing the confirmation 8 hearing on the Debtor’s First Amended Chapter 11 Plan from December 16, 2019 to 9 February 3, 2020 and requiring the Debtor to file a status report before the continued 10 confirmation hearing. Docket No. 174. The order continuing the confirmation hearing 11 indicated two deficiencies that the Debtor had failed to cure since the prior confirmation 12 hearing: (1) the Debtor’s failure to remove the temporary injunctive language from the plan, 13 as stated on the record at the November 14, 2019 evidentiary hearing; and (2) the Debtor’s 14 failure to file an employment contract of the Debtor’s principal, as contemplated under the 15 Debtor’s plan. Id. 16 On January 20, 2020, the Debtor filed a “Second Amended Chapter 11 Plan” (the 17 “Second Amended Plan,” Docket No. 179), which removed the temporary injunctive 18 language. On January 27, 2020, the Debtor filed an unsigned employment contract 19 between Dominique De Rivel and the Debtor. Docket No. 181. 20 On February 3, 2020, the court held the continued confirmation hearing. The 21 Debtor failed to file a status report before the February 3, 2020 hearing but stated at the 22 hearing that there were no updates and that the Debtor sought confirmation of the Second 23 Amended Plan as proposed. The court questioned the Debtor regarding the plan’s 24 treatment of the Debtor’s principal, Dominique De Rivel, and stated that it interpreted the 25 Second Amended Plan’s language to propose that Ms. De Rivel would receive an 26 exclusive option to purchase 100% of the equity of the reorganized debtor for $50,000. 27 The Debtor’s counsel stated that he was “not comfortable” with the court’s 1 Amended Plan. The Debtor’s counsel argued that the court had two options: (1) find the 2 $50,000 contribution sufficient to satisfy the “new value” exception, in which case the old 3 equity, Ms. De Rivel, would retain all of the equity of the reorganized debtor over the 4 impaired Class 3 unsecured creditors; or (2) find the $50,000 contribution not sufficient to 5 be considered “new value,” and confirm the plan, which would still give Ms. De Rivel an 6 exclusive option to purchase all of the equity of the reorganized debtor for $50,000 from 7 the Class 3 unsecured creditors. 8 After a lengthy discussion where the court expressed concern with the way in which 9 the Debtor’s counsel had drafted the Second Amended Plan’s equity purchase option and 10 framed the issue before the court, the court continued the confirmation hearing to March 11 2, 2020 to allow the Debtor to file a further amended plan to clear up the drafting and to 12 allow the parties to file supplemental briefing on the “new value” contribution issue and 13 whether the proposed contribution was sufficient to “cram down” the impaired unsecured 14 creditors under § 1129(b). 15 On February 10, 2020, the Debtor filed the “Third Amended Chapter 11 Plan” (the 16 “Third Amended Plan” or the “Plan,” Docket No. 188) and a notice of the hearing on the 17 Third Amended Plan (Docket No. 190), but the Third Amended Plan and the notice gave 18 notice of an incorrect continued confirmation hearing date of March 3, 2020. Based on the 19 notice deficiency, on February 25, 2020, the court continued the confirmation hearing from 20 March 2, 2020 to March 16, 2020. Docket No. 198.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Green Pharmaceuticals, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/green-pharmaceuticals-inc-cacb-2020.